2018 KHRS Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Korean Patients with Atrial Fibrillation: How to Initiate and Organize the Follow-up-Reference-Cited by-同舟云学术

2018 KHRS Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Korean Patients with Atrial Fibrillation: How to Initiate and Organize the Follow-up

Published:2019-02-01 Issue:1 Volume:94 Page:17-39
ISSN:1738-9364
Container-title:The Korean Journal of Medicine
language:en
Short-container-title:Korean J Med

Author:

Park Jin-Kyu,Kim Jun,Baek Yong Soo,Lee So-Ryoung,Hwang You Mi,Kim Tae-Hoon,Lee Dae In,Lee Ki Hong,Shim Jaemin,Joung Boyoung

Publisher

Korean Association of Internal Medicine

Subject

General Economics, Econometrics and Finance

Link

http://ekjm.org/upload/kjm-2019-94-1-17.pdf

Reference178 articles.

1. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

2. 2017 ESC/EACTS Guidelines for the management of valvular heart disease

3. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)

4. Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease

5. Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real World Outcomes of Direct Oral Anticoagulant in End Stage Kidney Disease on Dialysis;Journal of Korean Dialysis Access;2024-05-25

2. Design and Optimization of Rivaroxaban-Cyclodextrin-Polymer Triple Complex Formulation with Improved Solubility;Drug Design, Development and Therapy;2022-12

3. Factors Influencing the Selection of Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Non-Valvular Atrial Fibrillation;Journal of Cardiovascular Pharmacology and Therapeutics;2021-09-24